- Home
- AURA vs ABSI Comparison
AURA vs ABSI Comparison
Compare AURA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURA
- ABSI
- Stock Information
- Founded
- AURA 2007
- ABSI 2011
- Country
- AURA United States
- ABSI United States
- Employees
- AURA N/A
- ABSI N/A
- Industry
- AURA Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- AURA Health Care
- ABSI Health Care
- Exchange
- AURA Nasdaq
- ABSI Nasdaq
- Market Cap
- AURA 370.1M
- ABSI 353.8M
- IPO Year
- AURA 2021
- ABSI 2021
- Fundamental
- Price
- AURA $6.16
- ABSI $2.73
- Analyst Decision
- AURA Strong Buy
- ABSI Strong Buy
- Analyst Count
- AURA 5
- ABSI 5
- Target Price
- AURA $22.60
- ABSI $8.40
- AVG Volume (30 Days)
- AURA 243.1K
- ABSI 3.0M
- Earning Date
- AURA 05-15-2025
- ABSI 05-13-2025
- Dividend Yield
- AURA N/A
- ABSI N/A
- EPS Growth
- AURA N/A
- ABSI N/A
- EPS
- AURA N/A
- ABSI N/A
- Revenue
- AURA N/A
- ABSI $4,815,000.00
- Revenue This Year
- AURA N/A
- ABSI $145.79
- Revenue Next Year
- AURA N/A
- ABSI $99.29
- P/E Ratio
- AURA N/A
- ABSI N/A
- Revenue Growth
- AURA N/A
- ABSI N/A
- 52 Week Low
- AURA $4.35
- ABSI $2.01
- 52 Week High
- AURA $12.38
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- AURA 56.59
- ABSI 45.23
- Support Level
- AURA $5.68
- ABSI $2.59
- Resistance Level
- AURA $6.30
- ABSI $2.84
- Average True Range (ATR)
- AURA 0.48
- ABSI 0.20
- MACD
- AURA 0.07
- ABSI -0.01
- Stochastic Oscillator
- AURA 88.75
- ABSI 15.60
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.